Latest News & Features
Asia
Pharmaceutical company Teva has bought Allergan Generics from drugs business Allergan in a $40.5 billion deal. 27 July 2015
Americas
Biotechnology company United Therapeutics has sued Watson Laboratories claiming it has infringed three of its patents covering one of its hypertension treatment drugs. 24 July 2015
Americas
Enzo Life Sciences has agreed to settle a patent infringement dispute with Siemens Healthcare Diagnostics, in what was one of 12 cases that Enzo had filed simultaneously. 24 July 2015
Americas
The US Court of Appeals for the Federal Circuit’s decision in Amgen v Sandoz is what the biosimilar industry would have been hoping for but clarity is lacking in several areas, lawyers have told LSIPR. 23 July 2015
Americas
Law firm Hughes Hubbard & Reed has expanded its intellectual property practice by hiring Patrice Jean as a partner. 23 July 2015
Americas
Biopharma parties thinking about challenging a patent via an inter partes review should be aware that there are significant differences between district court and IPR practice, as Tasha Francis and Dorothy Whelan of Fish & Richardson explain. 23 July 2015
Americas
The US Court of Appeals for the Federal Circuit has ruled that biosimilar applicants can opt out of the so-called patent dance, paving the way for Sandoz to sell a biosimilar version of an Amgen drug. 22 July 2015
Big Pharma
A new parliamentary group has been created to raise awareness of and help to develop the life sciences industry in the UK. 21 July 2015
Asia
Police in China have reportedly seized 20,000 boxes of counterfeit drugs and detained more than 20 people thought to be selling them online. 20 July 2015
Americas
The US Court of Appeals for the Federal Circuit has upheld a ruling from the Patent Trial and Appeal Board that invalidated three patents owned by Columbia University covering DNA sequencing. 20 July 2015